Nu Skin Enterprises (NYSE:NUS) Issues FY 2026 Earnings Guidance

Key Points

• FY2026 guidance: Nu Skin issued EPS guidance of $0.70–$1.10 (consensus $1.00) and revenue guidance of $1.4–$1.5 billion, and updated Q2 EPS to $0.15–$0.25.
• Stock/valuation reaction: Shares fell to $7.05 after the update; the company has a market cap of about $339 million, a P/E of 2.2 and a 12‑month range of $5.78–$14.62.
• Dividend and analyst view: Nu Skin pays a quarterly dividend of $0.06 (annualized $0.24, yield 3.4%), analysts have a consensus “Hold” rating, and institutional investors own roughly 82.8% of the stock.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 0.700-1.100 for the period, compared to the consensus EPS estimate of 1.000. The company issued revenue guidance of $1.4 billion-$1.5 billion, compared to the consensus revenue estimate of $1.4 billion. Nu Skin Enterprises also updated its Q2 2026 guidance to 0.150-0.250 EPS.

Nu Skin Enterprises Stock Performance

NUS stock traded down $0.30 during midday trading on Thursday, hitting $7.05. 539,230 shares of the company traded hands, compared to its average volume of 510,137. Nu Skin Enterprises has a twelve month low of $5.78 and a twelve month high of $14.62. The stock has a market capitalization of $339.08 million, a price-to-earnings ratio of 2.20 and a beta of 1.03. The company has a quick ratio of 1.40, a current ratio of 2.08 and a debt-to-equity ratio of 0.25. The business has a 50 day simple moving average of $7.51 and a 200-day simple moving average of $9.24.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its earnings results on Thursday, May 7th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). Nu Skin Enterprises had a net margin of 10.79% and a return on equity of 8.14%. The firm had revenue of $320.61 million during the quarter, compared to analyst estimates of $329.70 million. Nu Skin Enterprises has set its FY 2026 guidance at 0.700-1.100 EPS and its Q2 2026 guidance at 0.150-0.250 EPS. As a group, equities research analysts predict that Nu Skin Enterprises will post 1 earnings per share for the current year.

Nu Skin Enterprises Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 11th. Stockholders of record on Friday, February 27th were given a dividend of $0.06 per share. The ex-dividend date of this dividend was Friday, February 27th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.4%. Nu Skin Enterprises's dividend payout ratio is currently 7.50%.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Zacks Research upgraded Nu Skin Enterprises from a "strong sell" rating to a "hold" rating in a research note on Monday, April 13th. Weiss Ratings reissued a "hold (c)" rating on shares of Nu Skin Enterprises in a research report on Thursday, January 22nd. Finally, Wall Street Zen lowered Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research note on Saturday, February 14th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Nu Skin Enterprises has a consensus rating of "Hold".

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Charles Schwab Investment Management Inc. raised its holdings in shares of Nu Skin Enterprises by 22.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,621,785 shares of the company's stock valued at $25,222,000 after purchasing an additional 481,231 shares during the last quarter. AQR Capital Management LLC boosted its stake in shares of Nu Skin Enterprises by 59.2% during the 4th quarter. AQR Capital Management LLC now owns 799,120 shares of the company's stock worth $7,688,000 after buying an additional 297,071 shares during the last quarter. Millennium Management LLC increased its position in shares of Nu Skin Enterprises by 1,167.2% in the fourth quarter. Millennium Management LLC now owns 275,100 shares of the company's stock valued at $2,646,000 after acquiring an additional 253,390 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Nu Skin Enterprises by 16.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,373,372 shares of the company's stock worth $13,212,000 after purchasing an additional 193,987 shares during the last quarter. Finally, Bridgeway Capital Management LLC increased its holdings in shares of Nu Skin Enterprises by 84.4% in the third quarter. Bridgeway Capital Management LLC now owns 396,725 shares of the company's stock valued at $4,836,000 after purchasing an additional 181,601 shares during the last quarter. 82.84% of the stock is currently owned by institutional investors.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.